Aim Botulinum toxin type A (BoNT‐A) injections were used in the treatment of lower‐limb
spasticity in children with cerebral palsy (CP). Anecdotal evidence suggests a reduction in …

Results There were no adverse effects of the treatment. Spasticity decreased by one point or
more on the Ashworth scale in 20 hips at month 1 and remained low at month 3 in 14, and at …

Postoperative pain in children with spastic cerebral palsy (CP) is often attributed to muscle
spasm and is difficult to manage using opiates and benzodiazepines. Adductor-release …

Hip displacement is the second most common deformity after equinus in children with
cerebral palsy (CP), and may result in dislocation, pain, fixed deformity and loss of function …

Aim To study the long‐term impact of 3 years of botulinum toxin A (BoNT‐A) injections and
abduction bracing on hip development in children with bilateral spastic cerebral palsy (CP) …

We investigated the effect of BoNT/A injection on hip lateralisation in children with bilateral
spastic cerebral palsy and bilateral adductor spasticity. Pelvic radiographs using Reimers' …

Objectives In the last 2 decades, BTX-A is increasingly being used in the management of
spasticity in children with Cerebral Palsy (CP) and there is no doubt about its effect on range …

Objective To test the hypothesis that pain would be reduced after botulinum toxin type A
(Btx/A) treatment for children with cerebral palsy (CP). Method Thirty-four pediatric patients …

Purpose To prospectively evaluate long-term effects of repeated botulinum toxin A (BTX-A)
injections in children with cerebral palsy (CP). Methods Repeated injections of BTX-A were …

Botulinum A toxin produces selective and reversible chemodenervation that can be
employed to balance muscle forces across joints in children with cerebral palsy (CP) …